Chemotherapy induced liver abnormalities: an imaging perspective

scientific article

Chemotherapy induced liver abnormalities: an imaging perspective is …
instance of (P31):
scholarly articleQ13442814
case reportQ2782326

External links are
P356DOI10.3350/CMH.2014.20.3.317
P932PMC publication ID4197183
P698PubMed publication ID25320738
P5875ResearchGate publication ID266974531

P2093author name stringAnkush Sharma
Rajesh Gulati
Chandana Lall
Joon-Il Choi
Priya Bhosale
Roozbeh Houshyar
P2860cites workVeno-occlusive disease in patients receiving thiopurines during maintenance therapy for childhood acute lymphoblastic leukaemiaQ33356939
Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injuryQ33386601
Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injuryQ33389221
Metabolic and toxic effects of mithramycin during tumor therapyQ33462982
Intestinal and liver toxicity of antineoplastic drugsQ33605823
Hepatotoxicity of chemotherapyQ33942794
Review article: updates in the pathogenesis and therapy of hepatic sinusoidal obstruction syndromeQ34481791
Neoadjuvant treatment of colorectal liver metastases is associated with altered contrast enhancement on computed tomographyQ35495938
A prospective, randomized study on hepatotoxicity of anastrozole compared with tamoxifen in women with breast cancerQ35713616
Pseudocirrhosis as a complication after chemotherapy for hepatic metastasis from breast cancerQ36983555
Monoclonal antibodies for B-cell lymphomas: rituximab and beyondQ37007354
Combined anti-proliferative and anti-angiogenic strategies for cancerQ37111832
Pseudocirrhosis in a pancreatic cancer patient with liver metastases: a case report of complete resolution of pseudocirrhosis with an early recognition and managementQ37220914
Hepatic sinusoidal obstruction syndrome caused by herbal medicine: CT and MRI featuresQ37640143
Sinusoidal obstruction syndrome after oxaliplatin-based chemotherapy.Q37711334
Radiologic mimics of cirrhosisQ37716391
CT findings of chemotherapy-induced toxicity: what radiologists need to know about the clinical and radiologic manifestations of chemotherapy toxicityQ37823777
Cyclophosphamide-induced liver necrosis: a possible interaction with azathioprineQ39550067
Morphologic spectrum of drug-induced hepatic diseaseQ41072410
Evaluation of Possible Chronic Hepatotoxicity From Methotrexate for PsoriasisQ42238881
Veno-occlusive liver disease after dacarbazine therapy (DTIC) for melanomaQ42250859
Hepatic veno-occlusive disease due to DTIC.Q42272033
Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphomaQ42982217
Development of cell-cycle inhibitors for cancer therapyQ43145495
Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patientsQ43909299
Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastasesQ46515428
Hepatic capsular retraction in metastatic carcinoma of the breast occurring with increase or decrease in size of subjacent metastasisQ47428622
Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases.Q53397241
Acute portal vein thrombosis after autologous stem cell transplantation.Q55066790
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomasQ57718877
Thrombotic complications during L-asparaginase treatment for acute lymphocytic leukemiaQ67236664
Biliary sclerosis in patients receiving hepatic arterial infusions of floxuridineQ67274373
Mechanisms of interleukin-2-induced hepatic toxicityQ70908362
Drug-induced hepatotoxicityQ71758942
CT of the liver in patients with metastatic breast carcinoma treated by chemotherapy: findings simulating cirrhosisQ72888688
Portal vein thrombosis after hematopoietic cell transplantation: frequency, treatment and outcomeQ77769238
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P433issue3
P921main subjectchemotherapyQ974135
P304page(s)317-326
P577publication date2014-09-01
P1433published inClinical and molecular hepatologyQ26853927
P1476titleChemotherapy induced liver abnormalities: an imaging perspective
P478volume20

Reverse relations

cites work (P2860)
Q58869838A New Model for MR Evaluation of Liver Function with Gadoxetic Acid, Including Both Uptake and Excretion
Q36307995Cancer therapy related complications in the liver, pancreas, and biliary system: an imaging perspective
Q88636540Effect of ursodeoxycholic acid and vitamin E in the prevention of liver injury from methotrexate in pediatric leukemia
Q60045418IDEAL-IQ in an oncologic population: meeting the challenge of concomitant liver fat and liver iron
Q90754497Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer
Q41951885Pseudocirrhosis in Gastric Cancer with Diffuse Liver Metastases after a Dramatic Response to Chemotherapy
Q92292207Quantitative magnetic resonance imaging evaluation of hepatic fat content with iron deposition: will it be disturbed?
Q38923545State-of-the-art cross-sectional liver imaging: beyond lesion detection and characterization
Q90533360Targeted Delivery of Cisplatin-Derived Nanoprecursors via a Biomimetic Yeast Microcapsule for Tumor Therapy by the Oral Route
Q28066568The Utilization of the Immune System in Lung Cancer Treatment: Beyond Chemotherapy

Search more.